Why do you need to move beyond first-line therapy for major depression?

Journal of Clinical Psychiatry

Volumn 71, Issue SUPPL. 1, 2010, Pages 4-9

  Culpepper, Larry ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; SERTRALINE;

ACUTE CORONARY SYNDROME; BRAIN DEPTH STIMULATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMORBIDITY; DIABETES MELLITUS; DISABILITY; DISEASE SEVERITY; DRUG CHOICE; ELECTROCONVULSIVE THERAPY; HOME CARE; HOSPITAL READMISSION; HUMAN; MAJOR DEPRESSION; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SCREENING; TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE STIMULATION;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DIABETES MELLITUS; DRUG RESISTANCE; ELECTRIC STIMULATION THERAPY; HEART DISEASES; HOSPITALIZATION; HUMANS; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK FACTORS;

EID: 78149335567     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.9104su1c.01     Document Type: Review

References (34)

1. O'Connor EA, Whitlock EP, Gaynes B, et al. Screening for Depression in Adults and Older Adults in Primary Care: An Updated Systematic Review. Rockville, MD: Agency for Healthcare Research and Quality; 2009. Evidence Report No. 75 AHRQ Publication No. 10-05143-EF-1.
2. Gaynes BN, Rush AJ, Trivedi MH, et al. Major depression symptoms in primary care and psychiatric care settings: a cross-sectional analysis. Ann Fam Med. 2007;5(2):126-134. doi:10.1370/afm.641 PubMed
3. Lorant V, Croux C, Weich S, et al. Depression and socio-economic risk factors: 7-year longitudinal population study. Br J Psychiatry. 2007;190(4):293-298. doi:10.192/bjp.bp.105.02040 PubMed
4. Lorant V, Deliège D, Eaton W, et al. Socioeconomic inequalities in depression: a meta-analysis. Am J Epidemiol. 2003;157(2):98-112. doi:10.1093/aje/kwf182 PubMed
5. Lynch JW, Kaplan GA, Shema SJ. Cumulative impact of sustained economic hardship on physical, cognitive, psychological, and social functioning. N Engl J Med. 1997;337(26):1889-1895. doi:10.1056/NEJM197125372606 PubMed
6. Meltzer H, Bebbington P, Brugha T, et al. Job insecurity, socio-economic circumstances and depression. Psychol Med. 2010;40(8):1401-1407. doi:10.1017/s032917091802 PubMed
7. Berlim MT, Fleck MP, Turecki G. Current trends in the assessment and somatic treatment of resistant/refractory major depression: an overview. Ann Med. 2008;40(2):149-159. doi:10.1080/07853890701769728 PubMed
8. Nemeroff CB. Prevalence and management of treatment-resistant depression. J Clin Psychiatry. 2007;68(suppl 8):17-25. PubMed
9. Fekadu A, Wooderson SC, Markopoulo K, et al. What happens to patients with treatment-resistant depression? a systematic review of medium to long term outcome studies. J Affect Disord. 2009;116(1-2):4-11. doi:10.1016/j.jad.208.10. 014 PubMed
10. Iosifescu DV. Treating depression in the medically ill. Psychiatr Clin North Am. 2007;30(1):77-90. doi:10.1016/j.psc.206.12.08 PubMed
11. Carney RM, Freedland KE. Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry. 2009;166(4):410-417. doi:10.176/api.ajp.208.08081239 PubMed
12. Glassman AH, Bigger JT Jr, Gaffney M. Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch Gen Psychiatry. 2009;66(9):1022-1029. doi:10.101/archgenpsychiatry.209.121 PubMed
13. de Voogd JN, Wempe JB, Koëter GH, et al. Depressive symptoms as predictors of mortality in patients with COPD. Chest. 2009;135(3):619-625. doi:10.1378/chest.08-078 PubMed
14. Katon W, Russo J, Lin EH, et al. Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification? Psychosom Med. 2009;71(9):965-972. doi:10.1097/PSY.0b013e3181bd8f5 PubMed
15. Kartha A, Anthony D, Manasseh CS, et al. Depression is a risk factor for rehospitalization in medical inpatients. Prim Care Companion J Clin Psychiatry. 2007;9(4):256-262. doi:10.408/PC.v09n0401 PubMed
16. Dunner DL, Rush AJ, Russell JM, et al. Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression. J Clin Psychiatry. 2006;67(5):688-695. doi:10.408/JCP.v67n0501 PubMed
17. World Health Organization. The Global Burden of Disease: 2004 Update. Geneva, Switzerland: WHO Press; 2008. http://www.who.int/healthinfo/global- burden-disease/GBD-report-2004update-full.pdf. Accessed March 22, 2010.
18. Greden JF. The burden of disease for treatment-resistant depression. J Clin Psychiatry. 2001;62(suppl 16):26-31. PubMed
19. Ani C, Bazargan M, Hindman D, et al. Comorbid chronic illness and the diagnosis and treatment of depression in safety net primary care settings. J Am Board Fam Med. 2009;22(2):123-135. doi:10.312/jabfm.209.02.08035 PubMed
20. U.S. Preventive Services Task Force. Screening for depression in adults: U.S. preventive services task force recommendation statement. Ann Intern Med. 2009;151(11):784-792. PubMed
21. National Council for Community Behavioral Healthcare. Behavioral Health/Primary Care Integration and the Person-Centered Healthcare Home (Discussion Paper). Washington, DC: National Council for Community Behavioral Healthcare; 2009. http://www.thenationalcouncil.org/galleries/resources- services%20files/Integration%20and%20Healthcare%20Home.pdf. Accessed March 23, 2010.
22. University of Washington, Department of Psychiatry and Behavioral Sciences. IMPACT: Evidence-based depression care. http://impact-uw.org. Published October 26, 2009. Accessed March 23, 2010.
23. Unützer J, Katon W, Callahan CM, et al, for the Improving Mood-Promoting Access to Collaborative Treatment (IMPACT) Investigators. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288(22):2836-2845. doi:10.101/jama.28.2.2836 PubMed
24. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. doi:10.1046/j.1525-1497.201.01609606.x PubMed
25. Amital D, Fostick L, Silberman A, et al. Serious life events among resistant and non-resistant MDD patients. J Affect Disord. 2008;110(3):260-264. doi:10.1016/j.jad.208.01.06 PubMed
26. Souery D, Oswald P, Massat I, et al, for the Group for the Study of Resistant Depression. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry. 2007;68(7):1062-1070. doi:10.408/JCP.v68n0713 PubMed
27. Rush AJ, Warden D, Wisniewski SR, et al. STAR*D: revising conventional wisdom. CNS Drugs. 2009;23(8):627-647. PubMed
28. US National Institutes of Health. Sequenced Treatment Alternatives to Relieve Depression (STAR*D). http://clinicaltrials.gov/show/NCT00021528. Published September 24, 2009. Accessed April 21, 2010.
29. Manning JS. What alternatives to first-line therapy for depression are effective? J Clin Psychiatry. 2010;71(suppl 1):10-15.
30. Nelson JC, Papakostas GI. Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. Am J Psychiatry. 2009;166(9):980-991. doi:10.176/api.ajp.209.09030312 PubMed
31. Weisler RH. How do you choose a second-line treatment option for depression? J Clin Psychiatry. 2010;71(suppl 1):21-26.
32. Kennedy SH, Giacobbe P. Treatment resistant depression: advances in somatic therapies. Ann Clin Psychiatry. 2007;19(4):279-287. doi:10.1080/ 104012307016752 PubMed
33. Lam RW, Chan P, Wilkins-Ho M, et al. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry. 2008;53(9):621-631. PubMed
34. Malone DA Jr, Dougherty DD, Rezai AR, et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry. 2009;65(4):267-275. doi:10.1016/j.biopsych.208.08.029 PubMed